Computer prediction of acute toxicity of thioderivatives of 3,5-bis(5-mercapto-4-R-4H-1,2,4-triazol-3-yl)phenol
DOI:
https://doi.org/10.14739/2409-2932.2024.3.312443Keywords:
1,2,4-triazole, acute toxicity, biological activityAbstract
This study presents the computational prediction of acute toxicity for new derivatives of 3,5-bis(5-mercapto-4-R-4H-1,2,4-triazol-3-yl)phenols and their alkylated analogues.
The aim of the work was to evaluate the impact of structural changes, particularly alkylation and chain length extension, on the toxicity levels of new derivatives of 3,5-bis(5-mercapto-4-R-4H-1,2,4-triazol-3-yl)phenols and their alkylated analogues.
Materials and methods. QSAR methodologies were used to predict toxicity, allowing the evaluation of toxicological properties based on molecular descriptors. Toxicity modeling was performed using computer software, enabling the estimation of toxicity without the need for in vivo experimental studies.
Results. The results showed, that alkylation of 3,5-bis(5-mercapto-4-R-4H-1,2,4-triazol-3-yl)phenol derivatives does not lead to a significant toxicity reduction. Moreover, an increase in toxicity was observed with the prolongation of the carbon chain in the synthesized compounds. It was also found, that acid derivatives, particularly 2,2’-(((5-hydroxy-1,3-phenylene)bis(4-R-4H-1,2,4-triazol-5,3-diyl))bis(sulfanyl))diacetate acids and 3,3’-((((5-hydroxy-1,3-phenylene)bis(4-R-4H-1,2,4-triazol-5,3-diyl))bis(sulfanyl))bis(methylene))dibenzoyl acids, exhibit toxicity ranging from 521.9 mg/kg to 2232.2 mg/kg, corresponding to toxicity class IV (low toxicity) on the OECD scale. It was found, that molecular structure and hydrophobic properties play a crucial role in determining compound toxicity. This study helps to establish a structure-toxicity relationship and to optimize compound structures for reduced toxicity.
Conclusions. These results provide a foundation for further development of potential drug candidates with predicted toxicological properties.
References
Shcherbyna R, Pruhlo Y, Duchenko M, Kulagina M, Kudria V, Vashchuk V. Evaluation of Antioxidant Activity of 1, 2, 4-Triazole Derivatives With Morpholine Moiety. Hacettepe University Journal of the Faculty of Pharmacy. 2022;42(2):73-82. doi: https://doi.org/10.52794/hujpharm.1033112
Shcherbak MO. [The research of synthetic, physical-chemical and biological properties of 4-amino-5-(2-, 3-, 4-nitrophenyl)-1,2,4-triazole-3-thiones and their N- and S-substituted] [dissertation on the Internet]. Zaporizhzhia, (Ukraine): Zaporozhye State Medical University; 2015 [cited 2024 Oct 1]. Available from: https://nrat.ukrintei.ua/en/searchdoc/0416U000154/
Sameliuk YG. [Synthesis and study of biologically active 1,2,4-triazoles-3-thione derivatives, which contain methoxyphenyl substituents] [dissertation on the Internet]. Zaporizhzhia, (Ukraine): Zaporozhye State Medical University; 2016 [cited 2024 Oct 1]. Available from: https://nrat.ukrintei.ua/en/searchdoc/0416U004113/
Kaplaushenko TM. [The search of biologically active compounds among 5-(quinolin-2-yl, 2-hydroxyquinoline-4-yl)-4-R-3-thio-1,2,4-triazoles and their derivatives] [dissertation on the Internet]. Zaporizhzhia, (Ukraine): Zaporozhye State Medical University; 2017 [cited 2024 Oct 1]. Available from: https://nrat.ukrintei.ua/en/searchdoc/0417U002356/
Dovbnya DV, Kaplaushenko AH, Frolova YS, Pruglo ES. Synthesis and antioxidant properties of new (2,4- and 3,4-dimethoxyphenyl)-1,2,4-triazoles. Pharmacia, 2022;69(1):135-42. doi: https://doi.org/10.3897/PHARMACIA.69.E74107
US EPA O. Toxicity Estimation Software Tool (TEST) [Internet]. www.epa.gov. 2015 [cited 2024 Sept 16]. Available from: https://www.epa.gov/comptox-tools/toxicity-estimation-software-tool-test
Dovbnia D, Frolova Y, Kaplaushenko A. A study of hypoglycemic activity of acids and salts containing 1,2,4-triazole. Ceska Slov Farm. 2023;72(3):113-24. English.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)